Search results (2147)
« Back to PublicationsActivity-based proteomics discovery of deubiquitinating enzyme inhibitors with immunomodulatory activity.
Jones HBL. et al, (2026), NPJ Drug Discov, 3
Selective USP32 inhibition reveals endosomal ubiquitin signaling and enables cell-permeable activity-based probes.
Scherpe S. et al, (2026), Cell Chem Biol
The autosomal deubiquitylase Trabid drives sex-divergent neurodegeneration in Drosophila
Xia J. et al, (2026), Communications Biology
Spatiotemporal co-regulation of IL2 and TCR receptors reveals early antigen-driven synaptic synergy in human CD8+ T cells.
Capera J. et al, (2026), Nat Commun, 17
DHODH is the key target of the KDM4 inhibitor QC6352 in glioblastoma stem cells.
Sterling JR. et al, (2026), Nat Chem Biol
The changing face of UK academic drug screening in the past decade.
Baronio R. and Ebner D., (2026), Nat Rev Drug Discov, 25, 809 - 810
Structures of the human sodium-citrate cotransporter NaCT with and without substrates.
Sauer DB. et al, (2026), Structure, 34, 1405 - 1413.e2
Ubiquitin chain editing promotes p97/VCP-dependent removal of RPA from DNA.
Drake M. et al, (2026), Mol Cell, 86, 3897 - 3914.e18
CD1a-autoreactive T cell sensing of skin barrier compromise.
Ottakandathil Babu R. et al, (2026), Br J Dermatol
Cross-Ancestry Proteogenomic Analyses Identified New Therapeutic Insights for Ischemic Heart Disease.
Mazidi M. et al, (2026), J Am Coll Cardiol, 88, 1107 - 1120
High-resolution structures of human NHE6 and NHE9 elucidate endosomal ion and lipid interactions.
Hansen JS. et al, (2026), Nat Commun, 17